| 0 (0%) | 12-12 23:26 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 319.64 | 1-year : | 323.22 |
| Resists | First : | 273.67 | Second : | 276.73 |
| Pivot price | 270.26 |
|||
| Supports | First : | 268.71 | Second : | 223.57 |
| MAs | MA(5) : | 270.76 |
MA(20) : | 270.45  |
| MA(100) : | 276.19 |
MA(250) : | 0 | |
| MACD | MACD : | -0.8 |
Signal : | -1.1 |
| %K %D | K(14,3) : | 75.4 |
D(3) : | 65 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 287.28 | Low : | 268.44 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LIAU ] has closed below upper band by 38.5%. Bollinger Bands are 54.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 270.98 - 272.35 | 272.35 - 273.23 |
| Low: | 267.41 - 269.27 | 269.27 - 270.46 |
| Close: | 268.11 - 270.9 | 270.9 - 272.68 |
Thu, 20 Nov 2025
Beating brain cancer through vaccines and research - UCLA Health
Fri, 31 Oct 2025
Shining a light on the dark matter of our genome - Harvard Gazette
Thu, 02 Oct 2025
Dr Tim Liau and Dr Rachel Leow longlisted for Inner Temple Book Prize - The London School of Economics and Political Science
Wed, 17 Sep 2025
Dr. Linda Liau honored with lifetime achievement award in medicine - UCLA Health
Thu, 31 Jul 2025
Elizabeth Liau | Women of Power 2025 - Prestige Hong Kong
Tue, 03 Jun 2025
Alexandra Hospital team patents new AI robotic knee surgery - BioWorld MedTech
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|